DEA Judge Notifies Agency Head About Marijuana Rescheduling Hearing Cancelation Following Appeal Order
A Drug Enforcement Administration (DEA) judge has advised the head of the agency that the ball is back in her court with respect to the Biden administration’s marijuana rescheduling proposal, providing notice of a request for leave to file appeal that he granted this week in the hearing proceedings.
DEA Judge Cancels Marijuana Rescheduling Hearing Set For Next Week
A DEA judge cancelled a hearing to consider a proposal to reclassify marijuana amid allegations that officials at the agency improperly conferred with witnesses.
DEA judge postpones cannabis rescheduling hearings, Marijuana Moment reports
DEA Administrative Law Judge John Mulrooney has canceled the first hearings on the proposal to reschedule cannabis to a Schedule III drug after
Why Delaying DEA’s Biased Marijuana Rescheduling Hearing Is Good For The Cannabis Industry (Op-Ed)
Had we not intervened, the hearing would have gone ahead with DEA openly tipping the scales against rescheduling.” By Michael DeGiglio, Village Farms & Robert Head, Hemp for Victory As the leaders of Village Farms and Hemp for Victory,
Cannabis Stocks Pull Back After DEA Postpones Rescheduling Hearings
Shares of the biggest cannabis stocks, including Curaleaf Holdings, Green Thumb Industries and Trulieve Cannabis were down between 3% and 6%. A DEA judge presiding over the Biden administration's rescheduling effort on Monday rejected a rescheduling supporter's motion to remove the DEA as a proponent of the rule change.
Judge postpones DEA hearing on proposed rescheduling of marijuana
A last-minute Biden administration effort to loosen restrictions on marijuana by rescheduling, or reclassifying it, as a less dangerous drug has come up short. An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week,
DEA Judge Cancels Marijuana Rescheduling Hearings Amid Legal Challenges, Pushing Back Reform For At Least Three Months
The first hearings on the Biden administration’s marijuana rescheduling proposal that were set for next week have now been canceled following a legal challenge from pro-reform witnesses, a Drug Enforcement Administration (DEA) judge has ruled.
DEA marijuana rescheduling hearing cancelled following legal challenge
A Drug Enforcement Agency hearing that was scheduled for Jan. 21 to discuss the Biden Administration's plans to reschedule marijuana has been cancelled due to a legal challenge from those who want the rescheduling to go through.
Hosted on MSN1d
DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances
Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain ...
Modern Healthcare2d
Biden's DEA pushes out remote prescribing proposal
The Drug Enforcement Administration proposed a special registration process for remote prescribing of controlled substances ...
Fierce Healthcare2d
DEA proposes long-awaited special registration for telehealth prescribing, with heightened scrutiny for virtual platforms
The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special ...
DEA proposes long-awaited rule for telehealth controlled substance prescriptions
However, telehealth advocates raised concerns about restrictions included in the rule, with one group asking President-elect ...
Modern Healthcare2d
DEA drug prescribing proposal may change providers' strategies
Telehealth companies aren't sure if the Trump administration will finalize the Biden administration's proposal around remote ...
DEA Ends Airport Gate Searches After Years of Documented Abuses of Civil Asset Forfeiture
The Drug Enforcement Administration (DEA) is ending searches of passengers at airports and other mass transit hubs after ...
McKnight's Long-Term Care News14h
DEA to propose telehealth prescribing registry; providers wary
Long-term care providers who prescribe controlled substances via telehealth may soon be subject to a tiered federal registration system.
Walgreens challenges DEA restrictions on opioids dispensing
Walgreens has sued the U.S. Drug Enforcement Administration alleging that it has unlawfully adopted new policies designed to ...